MMRI publishes breakthrough study detailing a novel approach to minimize damage after a heart attack.

A recent study conducted by Jason R. McCarthy, Ph.D., at the Masonic Medical Research Institute (MMRI) has revealed a potential breakthrough in minimizing damage after a heart attack. The study focuses on the use of biomimetic nanomaterials that target the spleen and deliver histone deacetylase (HDAC) inhibitors to modulate the inflammatory response. This targeted approach has shown promising results in reducing cardiac scar size and preserving heart function, even after just one dose. The findings have significant implications for the treatment of heart disease, which is the leading cause of death in the United States. McCarthy and his team plan to further investigate the mechanisms behind this therapeutic effect and explore the potential applications of these materials in other diseases. [Extracted from the article]

Copyright of Cardiovascular Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)